The risk of treatment. A study of rheumatoid arthritis patients' attitudes
- PMID: 9619900
- DOI: 10.1093/rheumatology/37.4.459
The risk of treatment. A study of rheumatoid arthritis patients' attitudes
Abstract
Despite its importance, there is no well-validated method of measuring patients' concept of 'acceptable' risk of medical treatment. Numerical methods give widely varying results depending on the methodology. We have attempted to assess 'acceptable' risk using relative comparisons. We administered a questionnaire to 67 patients with rheumatoid arthritis (RA). In general, patients' estimate of acceptable risk was less than the actual risk of treatment. Some illogical choices were made, showing poor understanding by patients of the concepts of risk and risk:benefit ratio. Patients appeared willing to accept higher levels of risk from procedures than from drug treatment. Willingness to accept risk in exchange for successful treatment of their RA did not correlate with disease severity, age, willingness to take non-medical risks or family responsibilities.
Similar articles
-
Risk communication in rheumatoid arthritis.J Rheumatol. 2003 Mar;30(3):443-8. J Rheumatol. 2003. PMID: 12610798
-
High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.J Rheumatol. 2002 Aug;29(8):1653-8. J Rheumatol. 2002. PMID: 12180724
-
Unwillingness of rheumatoid arthritis patients to risk adverse effects.Rheumatology (Oxford). 2002 Mar;41(3):253-61. doi: 10.1093/rheumatology/41.3.253. Rheumatology (Oxford). 2002. PMID: 11934960
-
Benefit/risk of therapies for rheumatoid arthritis: underestimation of the "side effects" or risks of RA leads to underestimation of the benefit/risk of therapies.Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S2-11. Clin Exp Rheumatol. 2004. PMID: 15552508 Review.
-
Measuring the effect of therapy in rheumatoid arthritis clinical trials from the patient's perspective.Curr Med Res Opin. 2014 Jul;30(7):1391-403. doi: 10.1185/03007995.2014.896328. Epub 2014 Apr 9. Curr Med Res Opin. 2014. PMID: 24716665 Review.
Cited by
-
Measuring pain impact versus pain severity using a numeric rating scale.J Gen Intern Med. 2012 May;27(5):555-60. doi: 10.1007/s11606-011-1926-z. Epub 2011 Nov 12. J Gen Intern Med. 2012. PMID: 22081365 Free PMC article.
-
Medication adherence in patients with rheumatoid arthritis: the effect of patient education, health literacy, and musculoskeletal ultrasound.Biomed Res Int. 2015;2015:150658. doi: 10.1155/2015/150658. Epub 2015 Apr 28. Biomed Res Int. 2015. PMID: 26060812 Free PMC article. Review.
-
Preferences of patients and health professionals for route and frequency of administration of biologic agents in the treatment of rheumatoid arthritis.Patient Prefer Adherence. 2014 Jan 20;8:93-9. doi: 10.2147/PPA.S55156. eCollection 2014. Patient Prefer Adherence. 2014. PMID: 24470758 Free PMC article.
-
Treating rheumatoid arthritis to target: the patient version of the international recommendations.Ann Rheum Dis. 2011 Jun;70(6):891-5. doi: 10.1136/ard.2010.146662. Epub 2011 Apr 7. Ann Rheum Dis. 2011. PMID: 21478190 Free PMC article.
-
Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?Rheumatol Int. 2016 Nov;36(11):1535-1542. doi: 10.1007/s00296-016-3566-4. Epub 2016 Sep 24. Rheumatol Int. 2016. PMID: 27665289 Review.
MeSH terms
Substances
LinkOut - more resources
Medical